DE68912115D1 - Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien. - Google Patents

Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien.

Info

Publication number
DE68912115D1
DE68912115D1 DE90900532T DE68912115T DE68912115D1 DE 68912115 D1 DE68912115 D1 DE 68912115D1 DE 90900532 T DE90900532 T DE 90900532T DE 68912115 T DE68912115 T DE 68912115T DE 68912115 D1 DE68912115 D1 DE 68912115D1
Authority
DE
Germany
Prior art keywords
thromboplastin
thromboplastin reagents
extraction
sensitivity
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90900532T
Other languages
English (en)
Other versions
DE68912115T2 (de
Inventor
Pamela Hawkins
James Maynard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dade Behring Inc
Original Assignee
Baxter Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Diagnostics Inc filed Critical Baxter Diagnostics Inc
Application granted granted Critical
Publication of DE68912115D1 publication Critical patent/DE68912115D1/de
Publication of DE68912115T2 publication Critical patent/DE68912115T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7454—Tissue factor (tissue thromboplastin, Factor III)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DE68912115T 1988-11-23 1989-11-03 Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien. Expired - Fee Related DE68912115T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27608388A 1988-11-23 1988-11-23
PCT/US1989/004867 WO1990005740A1 (en) 1988-11-23 1989-11-03 Improved extraction methods for preparing thromboplastin reagents

Publications (2)

Publication Number Publication Date
DE68912115D1 true DE68912115D1 (de) 1994-02-17
DE68912115T2 DE68912115T2 (de) 1994-08-11

Family

ID=23055093

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68912115T Expired - Fee Related DE68912115T2 (de) 1988-11-23 1989-11-03 Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien.

Country Status (9)

Country Link
US (1) US5426031A (de)
EP (1) EP0396733B1 (de)
JP (1) JP3348228B2 (de)
AT (1) ATE99697T1 (de)
CA (1) CA2002208C (de)
DE (1) DE68912115T2 (de)
DK (1) DK173090A (de)
NO (1) NO178578C (de)
WO (1) WO1990005740A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281528A (en) * 1989-12-18 1994-01-25 Warner-Lambert Company Process for purified thromboplastin for ultra-pure thrombin preparation
US5254350A (en) * 1991-07-22 1993-10-19 Helena Laboratories Corporation Method of preparing a thromboplastin extract
US5358853A (en) * 1992-08-03 1994-10-25 Akzo Av Liquid thromboplastin reagent
DE4407386B4 (de) * 1994-03-05 2009-01-15 Dade Behring Marburg Gmbh Verfahren zur Reaktivierung von gereinigten Membranproteinen durch Einfrieren
CA2165412A1 (en) * 1994-04-28 1995-10-29 Barry John Woodhams Calibrator for prothrombin time (pt) assays
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
EP1015890B1 (de) * 1997-04-23 2005-11-30 INSTRUMENTATION LABORATORY S.p.A. Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
ATE313068T1 (de) 1998-10-07 2005-12-15 Trinity Biotech Mfg Ltd Thromboplastin-reagenzien und verfahren zur herstellung und anwendung derselben
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
US20080260858A1 (en) * 2005-02-16 2008-10-23 The Board Of Trustees Of The University Of Illnois Universal Procoagulant
JP2008531692A (ja) * 2005-03-04 2008-08-14 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 凝固及び線維素溶解カスケードのモジュレーター
WO2009046194A2 (en) * 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
CN112481355B (zh) * 2020-11-16 2023-05-30 武汉市长立生物技术有限责任公司 液体型凝血酶原时间测定试剂盒及其制备方法
CN115166268B (zh) * 2022-08-02 2025-07-04 南京颐兰贝生物科技有限责任公司 一种凝血酶原时间检测试剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522148A (en) * 1965-08-13 1970-07-28 Dade Reagents Inc Stabilized thromboplastin preparation
JPS6366556A (ja) * 1986-09-09 1988-03-25 Fujitsu Ltd フオトマスクの修正方法
US5017556A (en) * 1986-11-04 1991-05-21 Genentech, Inc. Treatment of bleeding disorders using lipid-free tissue factor protein

Also Published As

Publication number Publication date
DE68912115T2 (de) 1994-08-11
DK173090D0 (da) 1990-07-19
DK173090A (da) 1990-07-19
NO903261L (no) 1990-07-20
EP0396733B1 (de) 1994-01-05
CA2002208A1 (en) 1990-05-23
WO1990005740A1 (en) 1990-05-31
EP0396733A1 (de) 1990-11-14
CA2002208C (en) 1998-02-24
JP3348228B2 (ja) 2002-11-20
NO178578C (no) 1996-04-24
ATE99697T1 (de) 1994-01-15
US5426031A (en) 1995-06-20
NO178578B (no) 1996-01-15
NO903261D0 (no) 1990-07-20
JPH03503534A (ja) 1991-08-08

Similar Documents

Publication Publication Date Title
DE68912115D1 (de) Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien.
DE69801210D1 (de) Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern
CA2252983C (en) Method for determining the anticoagulatory potential of a sample
AU591465B2 (en) Methods for coagulation monitoring
ATE78098T1 (de) Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen.
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
ATE100209T1 (de) Antikoerper verwendende diagnostische methoden.
DE3780485D1 (de) Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet.
ATE22928T1 (de) Verfahren zur bestimmung der wirksamkeit von plasminogen-aktivator des gewebes und zur verwendung in diesem verfahren geeigneter reagenzsatz.
Walenga et al. Newer avenues in the monitoring of antithrombotic therapy: The role of automation
DK0690991T4 (da) Ny antikoagulant-cofaktor-aktivitet
ATE16944T1 (de) Reagens zur optischen bestimmung des blutgerinnungsverhaltens.
DE60231144D1 (de) Test für niedrigmolekulares heparin, system und reagenz dafür
WO1998032389A1 (en) Method and apparatus for the measurement of blood coagulation properties with absorbent materials
ES2090106T3 (es) Metodo de asociacion quimica directa de dimero d procedente de una muestra biologica y que permite el diagnostico y el seguimiento de estados de trombolisis y de hipercoagulabilidad.
ATE191278T1 (de) Tetrahydroxychinon als eine aktivatorkomponente für den aktivierten partiellen thromboplastinzeit-test der blutgerinnung und als anzeiger von blutgerinnungsstörungen
Lippi et al. Preoperative screening: the rationale of measuring APTT in risk assessment
Quien et al. Plasma tissue factor antigen levels in capillary whole blood and venous blood: effect of tissue factor on prothrombin time
Hawkins et al. Extraction methods for preparing thromboplastin reagents
Simioni et al. Combined inherited protein S and heparin co-factor II deficiency in a patient with upper limb thrombosis: a family study
ES2157295T3 (es) Metodo para diagnosticar trastornos de la coagulacion de la sangre.
Dati et al. RESULTS OF THE MULTICENTRIC EVALUATION OF A NEW SYSTEM FOR PHOTOMETRIC DETERMINATION OF COAGULATION PARAMETERS
Bartl et al. APPLICATION OF THE ROUTINE PHOTOMETRIC COAGULATION ASSAYS PT, APTT AND FIBRINOGEN TO A CENTRIFUGAL ANALYZER
Poller et al. THE IMPLEMENTATION OF THE WHO INTERNATIONAL NORMALISED RATIO (INR) SYSTEM OF PROTHROMBIN TIME STANDARDISATION
McKernan et al. THE RELIABILITY OF THE INTERNATIONAL NORMALISED RATIO (INR) DURING SHORT TERM ORAL ANTICOAGULANT TREATMENT

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DADE BEHRING, INC.(N.D.GES.DES STAATES DELAWARE),

8339 Ceased/non-payment of the annual fee